Display options
Share it on

Mol Cell Oncol. 2016 Jun 10;4(2):e1198299. doi: 10.1080/23723556.2016.1198299. eCollection 2017.

Autophagic degradation of focal adhesions underlies metastatic cancer dissemination.

Molecular & cellular oncology

Marina N Sharifi, Erin E Mowers, Kay F Macleod

Affiliations

  1. The Ben May Department for Cancer Research, The University of Chicago, Chicago, IL, USA; Medical Scientist Training Program, The University of Chicago, Chicago, IL, USA; The Committee on Cancer Biology, The University of Chicago, Chicago, IL, USA.
  2. The Ben May Department for Cancer Research, The University of Chicago, Chicago, IL, USA; Medical Scientist Training Program, The University of Chicago, Chicago, IL, USA; Interdisciplinary Scientist Training Program, The University of Chicago, Chicago, IL, USA.
  3. The Ben May Department for Cancer Research, The University of Chicago, Chicago, IL, USA; The Committee on Cancer Biology, The University of Chicago, Chicago, IL, USA.

PMID: 28401177 PMCID: PMC5383354 DOI: 10.1080/23723556.2016.1198299

Abstract

Autophagy inhibition is being evaluated as a novel therapeutic strategy in multiple tumor types, but little is known about its implications for metastatic dissemination. We recently reported that autophagic degradation of paxillin through direct interaction with the autophagy protein LC3B is required for focal adhesion disassembly, Src-stimulated tumor cell motility, and metastasis.

Keywords: Autophagy; Src; cell motility; metastasis; paxillin

References

  1. Cancer Discov. 2014 Apr;4(4):466-79 - PubMed
  2. Proc Natl Acad Sci U S A. 2014 Jun 24;111(25):9241-6 - PubMed
  3. Cell. 2011 Oct 14;147(2):275-92 - PubMed
  4. J Cell Biol. 2016 Feb 29;212(5):577-90 - PubMed
  5. Carcinogenesis. 2013 Jun;34(6):1343-51 - PubMed
  6. Clin Cancer Res. 2012 Jan 15;18(2):370-9 - PubMed
  7. Nat Rev Mol Cell Biol. 2010 Sep;11(9):633-43 - PubMed
  8. EMBO J. 2015 Apr 1;34(7):856-80 - PubMed
  9. Cell Rep. 2016 May 24;15(8):1660-72 - PubMed
  10. Mol Cell. 2010 Oct 22;40(2):280-93 - PubMed

Publication Types

Grant support